| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 01/31/2002 | WO2002008185A1 Pyrrolidine derivatives as metalloprotease inhibitors |
| 01/31/2002 | WO2002007757A2 Prevention and treatment of sexual arousal disorders |
| 01/31/2002 | WO2002007718A1 Method for the treatment of climacteric disorders in women during or after the menopause |
| 01/31/2002 | WO2002007678A2 Mu-conopeptides |
| 01/31/2002 | WO2001062775A3 Novel antiarrhythmic peptides |
| 01/31/2002 | WO2001062341A3 Combination product for the treatment of obesity |
| 01/31/2002 | WO2001060832A3 Pluraflavins and derivatives thereof, process for their preparation and use thereof |
| 01/31/2002 | WO2001038503A3 Novel human protein kinases and protein kinase-like enzymes |
| 01/31/2002 | WO2001036605A3 2786, a human aminopeptidase |
| 01/31/2002 | US20020013357 Valdecoxib compositions |
| 01/31/2002 | US20020013334 HMG-CoA reductase inhibitors and method |
| 01/31/2002 | US20020013327 Administering estrogen agonist/antagonist, and optionally, co-administering an effective amount of a cyclic guanosine 3',5'-monophosphate elevator for therapy of female sexual dysfunction |
| 01/31/2002 | US20020013321 Used as ligands for opioid receptors, for therapy of neurological and gastrointestinal disorders |
| 01/31/2002 | US20020013304 As needed rather than involving chronic pharmacotherapy; formulations and kits |
| 01/31/2002 | US20020013289 P2Y2 and/or P2Y4 purinergic receptor agonists e.g., nucleotides of adenosine, cytidine and uridine, dinucleotides and analogs; treating vaginal dryness associated with menopause, chemotherapy, and diseases; vulvar pain |
| 01/31/2002 | US20020012694 For delivery of 7 alpha -methyl-19-nortestosterone (MENT) |
| 01/31/2002 | US20020012677 Pharmaceutical composition for treating dysmenorrhea and premature labor |
| 01/31/2002 | DE19881732C1 New phosphodiesterase inhibiting 2-phenyl-imidazotriazinone derivatives useful for treating e.g. cardiovascular, cerebrovascular and/or urogenital diseases |
| 01/31/2002 | CA2417127A1 Compounds and inhibitors of phospholipases |
| 01/31/2002 | CA2416691A1 Proteases |
| 01/31/2002 | CA2416544A1 Mu-conopeptides |
| 01/31/2002 | CA2415740A1 Pyrrolidine derivatives as metalloprotease inhibitors |
| 01/31/2002 | CA2415077A1 Cell cycle proteins and mitosis-associated molecules |
| 01/31/2002 | CA2415046A1 Novel form of (r)-n-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide |
| 01/31/2002 | CA2412626A1 Il-17 molecules and uses thereof |
| 01/31/2002 | CA2410562A1 Colchinol derivatives as angiogenesis inhibitors |
| 01/31/2002 | CA2354236A1 Use of glycogen phosphorylase inhibitors to inhibit tumor growth |
| 01/30/2002 | EP1176147A1 Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-ones and intermediates thereof |
| 01/30/2002 | EP1175433A1 Androgen glycosides and androgenic activity thereof |
| 01/30/2002 | EP1175413A1 2,1-benzisothiazoline 2,2-dioxides |
| 01/30/2002 | EP1175412A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 01/30/2002 | EP1175411A1 Cyclothiocarbamate derivatives as progesterone receptor modulators |
| 01/30/2002 | EP1175406A1 Imidazoline derivatives as alpha-1a adrenoceptor ligands |
| 01/30/2002 | EP1175404A1 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
| 01/30/2002 | EP1175398A1 Indoline derivatives as progesterone antagonists |
| 01/30/2002 | EP1175397A1 3,3-substituted indoline derivatives |
| 01/30/2002 | EP1175246A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS |
| 01/30/2002 | EP1175214A2 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 01/30/2002 | EP1175206A1 Pharmaceutical compositions comprising apocodeine and/or its derivatives |
| 01/30/2002 | EP1175204A1 Aerosol formulations and devices for increasing libido in women via acute testosterone administration |
| 01/30/2002 | EP1175203A1 Folic acid supplement |
| 01/30/2002 | EP1021442B1 8-azabicyclo 3.2.1] octane-3-methanamine derivatives as ligands of d2 and d3 dopamine and 5ht1a and 5ht2 serotonin receptors |
| 01/30/2002 | EP0891187B1 Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents |
| 01/30/2002 | EP0696919B1 Diagnosis and treatment of erectile dysfunction |
| 01/30/2002 | CN1333829A Polypeptide |
| 01/30/2002 | CN1333686A Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions |
| 01/30/2002 | CN1333339A Polytype gene of MXA protein and application thereof |
| 01/30/2002 | CN1333058A Anti-impotence kidney-tonifying capsule |
| 01/30/2002 | CN1333026A Medicine for treating hyperplasia of mammary glands |
| 01/30/2002 | CN1333024A Injection for mammary sland recovery |
| 01/30/2002 | CN1078474C Snuff for treating mastopathy and its inhalator |
| 01/29/2002 | US6343258 Method for testing for readiness for harvesting of tribulus terrestris l. having high steroidal saponin content |
| 01/29/2002 | US6342510 Antiinflammatory agents and enzyme inhibitors |
| 01/29/2002 | US6342498 Arylpiperazines as serotonin reuptake inhibitors and 5-HT1Dα antagonists |
| 01/29/2002 | US6342496 Bupropion metabolites and methods of use |
| 01/29/2002 | US6342251 Compositions for nasal administration |
| 01/29/2002 | US6342246 Image forms and method for ameliorating male erectile dysfunction |
| 01/29/2002 | CA2145296C Benzenealkanoic acids for cardiovascular diseases |
| 01/28/2002 | CA2354175A1 Process for the preparation of pyrazolo¬4,3-d|pyrimidin-7-one compounds and intermediates thereof |
| 01/24/2002 | WO2002006492A1 A novel human soluble secreted endopeptidase (sep) for the treatment of sexual dysunfction |
| 01/24/2002 | WO2002006349A1 Gel compositions containing metronidazole |
| 01/24/2002 | WO2002006288A1 Tetrahydro-heterocycloazepinyl pyrimidine derivatives |
| 01/24/2002 | WO2002006271A1 Pyrimidine derivatives |
| 01/24/2002 | WO2002006270A1 Novel 6-heteroarylphenanthridines |
| 01/24/2002 | WO2002006245A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
| 01/24/2002 | WO2002006242A2 5-substituted 2-aryl-4-pyrimidinones |
| 01/24/2002 | WO2002006231A1 Serotonin reuptake inhibitors |
| 01/24/2002 | WO2002006224A1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors |
| 01/24/2002 | WO2002006222A1 Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 01/24/2002 | WO2002005830A2 Extracts from crassulacean acid metabolism (cam) mechanism plants and uses thereof |
| 01/24/2002 | WO2002005828A1 Compositions and methods for the treatment of skin damage |
| 01/24/2002 | WO2002005811A1 Stem cell reinforcing material |
| 01/24/2002 | WO2002005808A1 Novel methods and compositions for the treatment or prevention of dysmenorrhoea and menstrual side effects: the use of phospholipase inhibitors |
| 01/24/2002 | WO2002005805A1 Method for inducing an estrous cycle and pregnancy in a female mammal |
| 01/24/2002 | WO2002005795A2 Pharmaceutical combinations for treatment and prevention of diabetes mellitus |
| 01/24/2002 | WO2002005794A2 Use of fluorescein derivatives for the treatment of diseases responsive to the activation of the cystic fibrosis transmembrane conductance regulator chloride channel |
| 01/24/2002 | WO2001076360A3 Synchronization of the cytoplasmatic and the nuclear maturation of oocytes in vitro |
| 01/24/2002 | WO2001046258A3 Transporters and ion channels |
| 01/24/2002 | WO2001034768A3 15 human secreted proteins |
| 01/24/2002 | WO2001023387A3 CERTAIN ALKYLENE DIAMINE-SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES |
| 01/24/2002 | WO2001019860A3 Proteins associated with cell differentiation |
| 01/24/2002 | WO2001014405A3 Methods of obtaining 2-methoxyestradiol of high purity |
| 01/24/2002 | WO2001012819A3 Protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 01/24/2002 | US20020010216 Mixture of norepinephrine reuptake inhibitors and antimuscarinic agents; treating disorders or diseases of the central nervous system, and particularly useful in treating incontinence. |
| 01/24/2002 | US20020010203 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| 01/24/2002 | US20020010198 Treatment of eating disorders, obesity, irritable bowel syndrome, obsessive-compulsive disorders, platelet adhesion, male and female sexual function disorders, restless leg syndrome, osteoarthritis |
| 01/24/2002 | US20020010189 For treatment of sexual disorders, male erectile dysfunction |
| 01/24/2002 | US20020010185 Anticarcinogenic agents |
| 01/24/2002 | US20020010183 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors |
| 01/24/2002 | US20020010167 An oral contraceptive starter kit comprising at least two cycle packs of oral contraceptives containing an estrogen and a progestin, and having penultimate cycle with greater steroid dosage than last cycle pack dosage |
| 01/24/2002 | US20020010163 Pregnacalciferol derivatives and corresponding 5,6-trans isomers exhibit anti-progesterone activity and may be useful as antineoplastic, antifertility, antiproliferative, immunosuppressive or antiinflammatory agents |
| 01/24/2002 | US20020009455 Prostate glands; diagnosis, therapy |
| 01/24/2002 | CA2416248A1 5-substituted 2-aryl-4-pyrimidinones |
| 01/24/2002 | CA2415935A1 Novel 6-heteroarylphenanthridines |
| 01/24/2002 | CA2415896A1 Use of fluorescein derivatives for the treatment of diseases responsive to the activation of the cystic fibrosis transmembrane conductance regulator chloride channel |
| 01/24/2002 | CA2415701A1 Compositions and methods for the treatment of skin damage |
| 01/24/2002 | CA2415665A1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors |
| 01/24/2002 | CA2415557A1 Compounds for the treatment of sexual dysfunction |
| 01/24/2002 | CA2415392A1 Pharmaceutical combinations for treatment and prevention of diabetes mellitus |
| 01/24/2002 | CA2384041A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |